DK175643B1 - Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af lægemidler - Google Patents

Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af lægemidler Download PDF

Info

Publication number
DK175643B1
DK175643B1 DK198900809A DK80989A DK175643B1 DK 175643 B1 DK175643 B1 DK 175643B1 DK 198900809 A DK198900809 A DK 198900809A DK 80989 A DK80989 A DK 80989A DK 175643 B1 DK175643 B1 DK 175643B1
Authority
DK
Denmark
Prior art keywords
endo
alkyl
hexahydro
methano
compounds
Prior art date
Application number
DK198900809A
Other languages
Danish (da)
English (en)
Other versions
DK80989D0 (da
DK80989A (da
Inventor
Maurice W Gittos
Michael G Palfreyman
Francis P Miller
Stephen M Sorensen
Hsien C Cheng
John R Fozard
Paul Moser
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88400417A external-priority patent/EP0329904A1/de
Priority claimed from EP88400418A external-priority patent/EP0329905A1/de
Priority claimed from EP88400415A external-priority patent/EP0329902A1/de
Priority claimed from EP88400416A external-priority patent/EP0329903A1/de
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of DK80989D0 publication Critical patent/DK80989D0/da
Publication of DK80989A publication Critical patent/DK80989A/da
Application granted granted Critical
Publication of DK175643B1 publication Critical patent/DK175643B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK198900809A 1988-02-23 1989-02-22 Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af lægemidler DK175643B1 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
EP88400417A EP0329904A1 (de) 1988-02-23 1988-02-23 Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln zur Behandlung von Anxietas
EP88400416 1988-02-23
EP88400418A EP0329905A1 (de) 1988-02-23 1988-02-23 Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln zur Erhöhung der Magenbeweglichkeit
EP88400415 1988-02-23
EP88400415A EP0329902A1 (de) 1988-02-23 1988-02-23 Verwendung von Chinolizinon- und Chinolizin-Derivaten zur Herstellung von Arzneimitteln zur Behandlung von Psychose
EP88400418 1988-02-23
EP88400417 1988-02-23
EP88400416A EP0329903A1 (de) 1988-02-23 1988-02-23 Verwendung von Chinolizinon- und Chinolizin-Derivaten zur Herstellung von Arzneimitteln zur Behandlung von Glaukom
US18563188A 1988-04-26 1988-04-26
US18563188 1988-04-26

Publications (3)

Publication Number Publication Date
DK80989D0 DK80989D0 (da) 1989-02-22
DK80989A DK80989A (da) 1989-08-24
DK175643B1 true DK175643B1 (da) 2005-01-03

Family

ID=27513624

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198900809A DK175643B1 (da) 1988-02-23 1989-02-22 Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af lægemidler

Country Status (10)

Country Link
EP (1) EP0329932B1 (de)
JP (1) JPH02288880A (de)
KR (1) KR890013018A (de)
AT (1) ATE129153T1 (de)
AU (1) AU624115B2 (de)
DE (1) DE68924545T2 (de)
DK (1) DK175643B1 (de)
ES (1) ES2080727T3 (de)
GR (1) GR3018299T3 (de)
IE (1) IE72504B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012569A1 (en) * 1989-04-21 1990-11-01 Sandoz Ag Therapeutic use of 5-ht3 receptor antagonists
EP0492020A1 (de) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Verwendung von bestimmten Estern von Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-on und verwandter Verbindungen zur Behandlung von kognitiven Erkrankungen
US5508287A (en) * 1992-02-24 1996-04-16 Merrell Pharmaceuticals Inc. 2,6-methano-2H-quinolizin derivative as 5-HT3 -receptor antagonist
NZ249346A (en) * 1992-02-24 1995-10-26 Merrell Dow Pharma 2,6-methano-2h-quinolizine ester derivatives and medicaments thereof
CA2679870A1 (en) * 2007-03-23 2008-10-02 Abbott Laboratories Azaadamantane ester and carbamate derivatives and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
DE3429830A1 (de) * 1983-08-26 1985-03-07 Sandoz-Patent-GmbH, 7850 Lörrach Automatische carbonsaeure- und sulfonsaeureester oder -amide
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
EP0191562B1 (de) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolonderivate
EP0405617A3 (en) * 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
GB8525913D0 (en) * 1985-10-21 1985-11-27 Beecham Group Plc Compounds
GB8511988D0 (en) * 1985-05-11 1985-06-19 Beecham Group Plc Compounds
GB8520616D0 (en) * 1985-08-16 1985-09-25 Beecham Group Plc Compounds
GB8523211D0 (en) * 1985-09-19 1985-10-23 Beecham Group Plc Compounds
EP0220011A3 (de) * 1985-10-12 1990-01-03 Beecham Group Plc Verwendung von Azabicycloalkylbenzamiden zur Behandlung von Magen-Darmbewegungskrankheiten, Migräne, Emesis, Migränekopfschmerzen, Trigeminusneuralgie und Arhythmie
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
ZA878096B (en) * 1986-11-03 1988-04-26 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds
EP0330788A1 (de) * 1988-03-01 1989-09-06 Merrell Dow Pharmaceuticals Inc. Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln zur Behandlung von Herz-Arrhythmie

Also Published As

Publication number Publication date
KR890013018A (ko) 1989-09-20
DK80989D0 (da) 1989-02-22
AU3021489A (en) 1989-08-24
IE72504B1 (en) 1997-04-23
EP0329932B1 (de) 1995-10-18
EP0329932A2 (de) 1989-08-30
ATE129153T1 (de) 1995-11-15
IE890564L (en) 1989-08-23
GR3018299T3 (en) 1996-03-31
EP0329932A3 (de) 1992-08-05
DE68924545T2 (de) 1996-03-21
DK80989A (da) 1989-08-24
AU624115B2 (en) 1992-06-04
DE68924545D1 (de) 1995-11-23
ES2080727T3 (es) 1996-02-16
JPH02288880A (ja) 1990-11-28

Similar Documents

Publication Publication Date Title
US5011846A (en) Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
US4826838A (en) Analgesic carbocyclic and heterocyclic carbonylmethylene-and carbonylmethypipidines and-pyrrolidines
CN100415716C (zh) 1－(1，2－双取代哌啶基)－4－取代哌嗪衍生物
US5248684A (en) Certain 2-oxo-quinoline carboxylates or corresponding carboxamides useful as anti-emetics and suppressants of migraine
JP3294611B2 (ja) ５−ｈｔ４レセプター・アンタゴニスト
NO175309B (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk virksomme tricykliske, nitrogenholdige forbindelser
JPH07504433A (ja) ５ｈｔ↓４−受容体アンタゴニストとしての縮合インドール誘導体
EA007429B1 (ru) Азабициклические замещённые конденсированные гетероарильные соединения
DE69111816T4 (de) Indolederivate und ihre verwendung als serotonin-antagoniste.
US5556851A (en) Cinnoline-3-carboxylic acid derivatives
JP3377227B2 (ja) あるメタノ架橋キノリジン類のアミド類似体類の誘導体類
US5955470A (en) Derivatives of amide analogs of certain methano bridged quinolizines
JPH08502273A (ja) ５−ｈｔ▲下４▼レセプターアンタゴニスト用複素環式エステルまたはアミド
DK175643B1 (da) Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af lægemidler
IE83573B1 (en) Derivatives of amide analogs of certain methano bridged quinolizines
US5096900A (en) (4-piperidyl)methyl-2,3-dihydro-1h-isoindole and -2,3,4,5-tetrahydro-1h-benzazepine derivatives, their preparation and their application in therapy
EA003991B1 (ru) Производные 2-аминопиридинов, способ ингибирования синтазы оксида азота, фармацевтические композиции и способы лечения
US5081128A (en) 2,3-dihydro-1h-isoindole derivatives and their application in therapy
EP0628043A1 (de) 216-methano-2h-quinolizine derivate als 5-ht3 rezeptor antagonist
WO2023208124A1 (zh) 哌啶甲酰胺氮杂茚满类衍生物及其制备方法和用途
CA2195157A1 (en) (1h-indol-4-yl)-piperidine or tetrahydropyridine ethylamines and ethylcarboxamides
EP0329903A1 (de) Verwendung von Chinolizinon- und Chinolizin-Derivaten zur Herstellung von Arzneimitteln zur Behandlung von Glaukom
EP0329905A1 (de) Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln zur Erhöhung der Magenbeweglichkeit
JPH05230057A (ja) 光学活性インダゾール―３―カルボキサミド誘導体及びそれを有効成分とする制吐剤
UA77447C2 (en) Azabicyclic-substituted fused heteroaryls, a pharmaceutical composition based thereon

Legal Events

Date Code Title Description
PUP Patent expired